听力与言语-语言病理学

行为科学

医学伦理学

你正在浏览ONCOLOGY期刊下所有文献
  • Intensive chemotherapy plus recombinant human granulocyte-colony stimulating factor support for distant metastatic nasopharyngeal carcinoma. A preliminary report.

    abstract::Nasopharyngeal carcinoma (NPC) has been shown to be highly responsive to chemotherapy. The major limiting toxicity was myelotoxicity. Recently, the role of granulocyte colony-stimulating factor (G-CSF) in reducing chemotherapy-induced neutropenic sepsis has been well established. In this study, we tested whether recom...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227658

    authors: Wang CH,Wang HM,Chen JS,Chang WJ,Lai GM

    更新日期:1997-01-01 00:00:00

  • Plasma thrombin-antithrombin complexes, latent coagulation disorders and metastatic spread in lung cancer: a longitudinal study.

    abstract::In patients affected with different tumours, disorders concerning clotting are frequently observed. The biological processes leading to coagulation are probably involved in the mechanisms of metastasis. We studied plasma levels of thrombin-antithrombin III complexes (TAT) in 90 patients affected with lung tumours subg...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227620

    authors: Tricerri A,Vangeli M,Errani AR,Guidi L,Canetta M,Vaccarino M,De Santis C,Ipsevich F,Salvati F,Bartoloni C

    更新日期:1996-11-01 00:00:00

  • Lack of c-mpl proto-oncogene transcripts and growth-stimulatory effects of thrombopoietin on human small cell lung cancer cell lines.

    abstract::Thrombopoietin (TPO) is a recently discovered hematopoietic growth factor which stimulates the production and maturation of megakaryocytes. In this study, we used a modified MTT assay to examine the in vitro growth-stimulatory effects of recombinant human (rh) TPO and recombinant human stem cell factor (rhSCF) on eigh...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227600

    authors: Shinohara A,Shimizu E,Takada M,Sone S

    更新日期:1996-09-01 00:00:00

  • Anal carcinoma: a clinical approach to p53 and RB gene proteins.

    abstract::The role of p53, retinoblastoma (RB) and c-erbB-2 gene proteins in the pathogenesis of anal carcinomas has been examined. A total of 97 patients were included in the study. c-erbB-2, RB and p53 proteins were abnormal in 0, 5 and 34% of the cases, respectively. No correlation was observed between p53 and age, sex, tumo...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227590

    authors: Tanum G,Holm R

    更新日期:1996-09-01 00:00:00

  • In vitro and in vivo growth inhibition of SC-M1 gastric cancer cells by retinoic acid.

    abstract::Retinoids are differentiating agents that have been used successfully for the treatment of acute promyelocytic leukemia. When combined with interferons, they are active in preventing second malignancies in patients with head and neck cancer. Our previous studies have demonstrated cytostatic effects of alltrans-retinoi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227583

    authors: Jiang SY,Shyu RY,Chen HY,Lee MM,Wu KL,Yeh MY

    更新日期:1996-07-01 00:00:00

  • Bone-specific alkaline phosphatase in plasma as tumour marker for osteosarcoma.

    abstract::The levels of bone-specific alkaline phosphatase (BALP) in plasma and tumour tissue samples of 20 Chinese patients with osteosarcoma in Hong Kong were measured by the wheat germ lectin precipitation technique. The plasma BALP levels in these patients were significantly higher than those of the normal subjects (p < 0.0...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227573

    authors: Liu PP,Leung KS,Kumta SM,Lee KM,Fung KP

    更新日期:1996-07-01 00:00:00

  • Antiemetic study methodology: recommendations for future studies.

    abstract::The methodology of future antiemetic studies will reflect the need to address the problems identified in current studies. New preclinical information on the mechanisms of emesis and antiemetic action will allow more rational clinical study design. Prior to large randomized studies, phase I and II trials should define ...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227648

    authors: Olver IN

    更新日期:1996-06-01 00:00:00

  • Models, mechanisms and management of anticipatory nausea and emesis.

    abstract::Anticipatory nausea and vomiting (ANV) are learned responses to chemotherapy that develop in up to 25% of patients by the fourth treatment cycle. Post-treatment nausea and emesis must occur before development of ANV can take place. Certain patient characteristics and other responses to chemotherapy can also be used to...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227633

    authors: Morrow GR,Rosenthal SN

    更新日期:1996-06-01 00:00:00

  • In vitro-in vivo correlation in anticancer drug sensitivity test using AUC-based concentrations and collagen gel droplet-embedded culture.

    abstract::To improve the ability of an in vitro drug sensitivity test to predict in vivo effects, we applied a drug concentration that was pharmacokinetically equivalent to plasma levels and collagen gel droplet-embedded culture with a high cloning efficiency. We reported that the cell-killing effect of cell cycle phase-nonspec...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227569

    authors: Inaba M,Tashiro T,Sato S,Ohnishi Y,Tanisaka K,Kobayashi H,Koezuka M

    更新日期:1996-05-01 00:00:00

  • Overexpression of c-ErbB-2 protein in gastric cancer by immunohistochemical stain.

    abstract::An immunohistochemical stain to the c-ErbB-2 protein was performed in 225 paraffin-embedded tissue blocks from patients with locally advanced gastric cancer who underwent curative resection. The overexpression of the c-ErbB-2 protein was observed in 27.4% of the patients. The c-ErbB-2 positivity showed a statistically...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227559

    authors: Lee HR,Kim JH,Uhm HD,Ahn JB,Rha SY,Cho JY,Lee JI,Lee KH,Chung HC,Roh JK,Min JS,Lee KS,Shin DH,Kim BS,Hong SW,Choi JH

    更新日期:1996-05-01 00:00:00

  • Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group Study.

    abstract::362 evaluable node-positive patients with stage II breast cancer were randomized, receiving either 6 cycles of conventional CMF or 6 cycles of the combination of cyclophosphamide (500 mg/m2), mitoxantrone (Novantrone 10 mg/m2), and fluorouracil (500 mg/m2; CNF). After a median follow-up of 51 months, 64 (36%) patients...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000227550

    authors: Fountzilas G,Polichronis A,Katsohis K,Gennatas K,Toussis D,Skarlos D,Kosmidis P,Vassilaros S,Semoglou C,Giannakakis T,Fahantidis E,Klouvas G,Tsavaris N,Konstantaras C,Makrantonakis P,Kolotas C,Zamboglou N,Tsiliakos S,

    更新日期:1996-03-01 00:00:00

  • Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone.

    abstract::The prognosis of brain glioblastoma is still very poor and the median survival time is generally less than 6 months. At present, no chemotherapy has appeared to influence its prognosis. On the other hand, recent advances in brain tumor biology have suggested that brain tumor growth is at least in part under a neuroend...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000227533

    authors: Lissoni P,Meregalli S,Nosetto L,Barni S,Tancini G,Fossati V,Maestroni G

    更新日期:1996-01-01 00:00:00

  • Acute disseminated intravascular coagulation syndrome in cancer patients.

    abstract::Hemostatic abnormalities are rather frequent in cancer patients either in hematological or in solid tumors. Acute disseminated intravascular coagulation (DIC) is a rare coagulopathy in cancer patients, but when it develops it becomes rapidly fatal. Between June 1988 and December 1992 we observed 8 cases of acute DIC o...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227520

    authors: Pasquini E,Gianni L,Aitini E,Nicolini M,Fattori PP,Cavazzini G,Desiderio F,Monti F,Forghieri ME,Ravaioli A

    更新日期:1995-11-01 00:00:00

  • Activity of formestane in de novo tamoxifen-resistant patients with metastatic breast cancer.

    abstract::In order to assess the feasibility of a sequential hormonal treatment after tamoxifen failure, 24 postmenopausal advanced breast cancer patients (median age 60 years; ECOG PS < or = 1) were treated with formestane (4-hydroxyandrostenedione) 250 mg i.m. fortnightly; 19 patients were estrogen receptor-positive. The site...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227510

    authors: Noberasco C,Bajetta E,Zilembo N,Di Leo A,Cappuzzo F,Bartoli C,Bono A,Bichisao E

    更新日期:1995-11-01 00:00:00

  • Effects of cycloheximide on chromatin-bound and -unbound PCNA in HeLa cells.

    abstract::We examined the effects of cycloheximide on the amount of chromatin-bound and -unbound PCNA subpopulations in HeLa cells. The chromatin-bound PCNA content decreased rapidly in the presence of cycloheximide, whereas the reduction of the total amount of PCNA was minimal even 24 h after the treatment with cycloheximide. ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227500

    authors: Sasaki K,Kurose A,Uesugi N,Kato A

    更新日期:1995-09-01 00:00:00

  • Surgery for exocrine pancreatic cancer--who are the 5- and 10-year survivors?

    abstract::38 of 306 patients survived beyond 5 years after resection of an exocrine pancreatic carcinoma during a period from 1971 to 1993. Amongst the long-term survivors there were 12 patients with ductal, 22 with ampullary, 3 with distal bile duct and 1 with duodenal cancer. An active operative strategy was employed in order...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227488

    authors: Klempnauer J,Ridder GJ,Bektas H,Pichlmayr R

    更新日期:1995-09-01 00:00:00

  • Histologic grade and cellular proliferation at the deepest invasive portion correlate with the high malignancy of submucosal invasive gastric carcinoma.

    abstract::To establish appropriate indications for endoscopic treatment of submucosal invasive gastric carcinoma, we investigated clinicopathologic features and proliferating cell nuclear antigen (PCNA) expression at the deepest invasive portion of 192 differentiated submucosal invasive gastric carcinomas that had been surgical...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227486

    authors: Nishida T,Tanaka S,Haruma K,Yoshihara M,Sumii K,Kajiyama G

    更新日期:1995-07-01 00:00:00

  • Relapse of Hodgkin's disease after ten years.

    abstract::We report four cases of Hodgkin's disease (HD) relapsing after complete remission for over a 10-year period after the initial therapy. Three of the patients had mixed-cellularity subtypes as a primary histological diagnosis, and the rebiopsies demonstrated mixed cellularity in all very late relapse cases. Two patients...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227474

    authors: Illés A,Bányai A,Vadász G,Szegedi G

    更新日期:1995-07-01 00:00:00

  • A phase II trial of cardioprotection with Cardioxane (ICRF-187) in patients with advanced breast cancer receiving 5-fluorouracil, doxorubicin and cyclophosphamide.

    abstract::From January 1991 to August 1993, 237 women with metastatic breast cancer were recruited into a multicentric phase II clinical trial designed to assess the cardioprotective activity of Cardioxane (ICRF-187). All patients were treated with 5-fluorouracil 500 mg/m2, doxorubicin 50 mg/m2, cyclophosphamide 500 mg/m2 (FDC)...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227467

    authors: Kolaric K,Bradamante V,Cervek J,Cieslinska A,Cisarz-Filipcak E,Denisov LE,Donat D,Drosik K,Gershanovic M,Hudziec P

    更新日期:1995-05-01 00:00:00

  • Long-term cosmetic outcome and toxicity in patients treated with quadrantectomy and radiation therapy for early-stage breast cancer.

    abstract::Breast conservation treatment followed, if useful, by adjuvant therapy is the treatment of choice in early breast cancer. Late cosmetic outcome and toxicity are important in comparing conservative treatment to mastectomy. We reviewed the records of 225 patients treated from 1981 to 1988 with a median follow-up of 74 m...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227454

    authors: Amichetti M,Busana L,Caffo O

    更新日期:1995-05-01 00:00:00

  • Perioperative blood transfusions and prognosis in patients with curatively resected locally advanced gastric cancer.

    abstract::Several reports have demonstrated an adverse effect of perioperative blood transfusions on the survival of patients with various solid tumors treated surgically. We retrospectively investigated the relationship between perioperative blood transfusions and the survival of 501 patients who underwent radical subtotal gas...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227452

    authors: Choi JH,Chung HC,Yoo NC,Lee HR,Lee KH,Kim JH,Roh JK,Min JS,Lee KS,Kim BS

    更新日期:1995-03-01 00:00:00

  • Flow cytometric analysis of the DNA content of tumor cells in cases of gastric cancer in the upper third of the stomach and in the remnant stomach.

    abstract::Thirteen samples of gastric tumors that had developed in the remnant stomach (remnant gastric cancer) were compared with 63 samples of primary gastric tumors located in the upper third of the stomach (primary gastric cancer) by both clinicopathologic and flow cytometric analysis. The depths of invasion of all these tu...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227441

    authors: Ikeguchi M,Kondou A,Oka A,Tsujitani S,Maeta M,Kaibara N

    更新日期:1995-03-01 00:00:00

  • A phase II trial of vindesine in hepatocellular cancer.

    abstract::Sixteen patients with histologically confirmed inoperable hepatocellular carcinoma were treated with vindesine 3 mg/m2 i.v. weekly. Anemia, leukopenia and neuritis were documented but no severe or life-threatening toxicity was seen. There were no objective responses among the 14 evaluable patients. Eight had a no chan...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227434

    authors: Falkson G,Burger W

    更新日期:1995-01-01 00:00:00

  • Surgical treatment and prognosis for patients with gastric cancer lesions larger than ten centimeters in size.

    abstract::In 323 of 1,620 patients with gastric cancer, the lesion was > or = 10 cm in maximum diameter. Studies were done with respect to clinicopathologic features and the prognosis. Patients with tumors > or = 10 cm were younger and women patients were more numerous compared to those with tumors < 10 cm. Tumors were more adv...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227424

    authors: Maehara Y,Oiwa H,Oda S,Sakaguchi Y,Endo K,Ohno S,Sugimachi K

    更新日期:1995-01-01 00:00:00

  • Testing prospective anticancer drugs against human tumors using simple in vivo models.

    abstract::The activities of established and experimental antitumor drugs were tested against the BRO and MeWo human melanomas transplanted in the subrenal capsule of phenotypically immunocompetent (CBA x C57BL/6)F1 mice. Immunosuppression was achieved with preliminary whole-body radiation, and cytological examination showed tha...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227400

    authors: Ryabkova VI,Lockshin A,Strukov IG,Sokolova VK

    更新日期:1994-11-01 00:00:00

  • Implications of flow cytometry in preoperative detection of biologic variables of gastric cancer and malignant condition of gastric remnant cells obtained by endoscopic biopsy.

    abstract::Flow cytometric (FCM) DNA studies were performed on cell suspensions obtained by endoscopic biopsy in 73 patients with gastric cancer and in 61 patients with gastric remnant. In cancer, DNA aneuploidies were detected in 49 tumors (67.1%), including 51.7% (15/29) of early gastric cancers and 77.3% (34/44) of advanced g...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227389

    authors: Kimura H,Kanno M,Takamura H,Arakawa H,Maeda K,Uogishi M,Sodani H,Kawashima T

    更新日期:1994-11-01 00:00:00

  • Malignant fibrous histiocytoma of the spleen and chronic myelogenous leukemia. A case report.

    abstract::We report a rare case of a patient with an intrasplenic malignant fibrous histiocytoma (MFH) and chronic myelogenous leukemia. The neoplasms were synchronous in their onset and evolution. The peculiarity of the primary site of the MFH, the genetic implications of multiple primary tumors in a single patient, and the co...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227384

    authors: Bonilla F,Provencio M,Fernandez E,España P

    更新日期:1994-09-01 00:00:00

  • Comparative effects of piroxicam and esculetin on incidence, proliferation, and cell kinetics of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in rats on high- and low-fat diets.

    abstract::We investigated the effects of piroxicam, a cyclooxygenase inhibitor, and esculetin, a lipoxygenase inhibitor, on 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary carcinogenesis in female rats. Seven days after receiving a 5-mg dose of DMBA, rats were fed either a high-fat (20% soybean oil) or low-fat (0.5% soybe...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227374

    authors: Kitagawa H,Noguchi M

    更新日期:1994-09-01 00:00:00

  • Phase II trial of cisplatin and etoposide as first-line therapy in metastatic breast carcinoma.

    abstract::Twenty-two patients with metastatic breast carcinoma were treated with a combination of cisplatin (100 mg/m2 i.v. day 1) and etoposide (100 mg/m2 i.v. days 1-3). Eligible patients had measurable disease with normal organ functions, performance status < 3, age < 70 years and no previous chemotherapy for metastatic dise...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227364

    authors: Lluch A,Azagra P,Cervantes A,Muñoz M,Alberola V,Santabarbara P,García-Conde J

    更新日期:1994-07-01 00:00:00

  • Primary gastric non-Hodgkin's lymphoma localized to the gastric wall: no adjuvant treatment following radical surgery.

    abstract::The paper presents the experience with watch-and-wait policy following radical surgery in 25 patients with primary gastric non-Hodgkin's (NH) lymphoma localized to the gastric wall. The median follow-up is at the moment 40 months (range 18-85). Only 3/25 patients have relapsed (during the first year of the follow-up) ...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227347

    authors: Jelić S,Kovcin V,Jovanović V,Oprić M,Milanović N

    更新日期:1994-05-01 00:00:00

  • Local interleukin-2 therapy for cancer, and its effector induction mechanisms.

    abstract::This paper reviews the effectiveness of local interleukin-2 (IL-2) therapy and its effector induction mechanisms in vivo. Local therapy with IL-2 and/or lymphokine-activated killer (LAK) cells is associated with far fewer side effects than systemic treatment. Local infusions of IL-2 into malignant pleural effusions an...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227331

    authors: Sone S,Ogura T

    更新日期:1994-03-01 00:00:00

  • Recombinant human granulocyte colony-stimulating factor in the management of cancer patients: five years on.

    abstract::Recombinant human granulocyte colony-stimulating factor (G-CSF) has been used worldwide in cancer patients for over 1 year, and (only 5 years from the first publication on the clinical use of this growth factor) experience is rapidly accumulating in many oncological situations. Several randomized studies have confirme...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227333

    authors: Bronchud MH

    更新日期:1994-03-01 00:00:00

  • Characterization of vincristine-resistant HOB1 lymphoma cell line showing the classical MDR phenotype and altered expression of membrane glycoproteins.

    abstract::A multidrug-resistant (MDR) cell line isolated from HOB1 lymphoma cells was characterized. The MDR phenotype in this cell line was typified by resistance to vincristine with varying degrees of cross-resistance to Adriamycin, colcemid and actinomycin D. Decreased intracellular [3H]vincristine with concurrent increase i...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227300

    authors: Lee WP,Lee CL

    更新日期:1994-01-01 00:00:00

  • Treatment of advanced primary lung cancer associated with malignant pleural effusion by the combination of immunotherapy and chemotherapy.

    abstract::Twelve patients with advanced primary lung cancers associated with malignant pleural effusion were treated with intrathoracic instillation of recombinant interleukin-2 with or without in-vitro-sensitized cells. Two cases achieved complete response, and 7 partial response. The adverse effects seen in the protocol were ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227317

    authors: Miyao H,Chou T,Ito K,Moriyama H,Mitsuma S,Wakabayashi M,Yoshizawa H,Arakawa M

    更新日期:1994-01-01 00:00:00

  • Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum.

    abstract::Of 352 patients with colorectal carcinoma followed for a minimum of 5 years after surgery, 39 cases (11.1%; median age 60 years) had mucinous adenocarcinoma, and 4 (1.1%; median age 62 years) had signet-ring cell carcinoma. Mucinous carcinomas were most frequently located in the rectum (61.5%) and in the sigmoid colon...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227306

    authors: Secco GB,Fardelli R,Campora E,Lapertosa G,Gentile R,Zoli S,Prior C

    更新日期:1994-01-01 00:00:00

  • Carboplatin in the treatment of non-small cell lung cancer: a review.

    abstract::Cisplatin is among the most active agents available for the therapy of non-small cell lung cancer (NSCLC). Its congener, carboplatin, has been the focus of intense clinical trials over the last several years because of its improved therapeutic index. Results from randomized trials have shown that carboplatin is active...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227259

    authors: Comis RL

    更新日期:1993-11-01 00:00:00

  • The effect of minocin on the pericardium.

    abstract::The purpose of this study was to evaluate in a dog model whether intrapericardial instillation of tetracycline is superior to the effect of drainage alone in causing pericardial adhesions and cavity obliteration. Twelve mongrel dogs were randomly divided into two experimental groups. All dogs received a pericardial dr...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227232

    authors: Markiewicz W,Ben-Arieh Y,Best L,Mordochovich D,Rinkevitch D

    更新日期:1993-11-01 00:00:00

  • Antitumorous and immunomodulatory effects of the Viscum album L. preparation Isorel.

    abstract::There are numerous data on the immunostimulative and antitumorous activity of various Viscum album tissue extracts. Isorel (Novipharm, Austria) is one of these compounds. We found that in mice an increased number of plaque-forming cells to sheep red blood cells (SRBC) followed the injection of Isorel together with SRB...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227217

    authors: Jurin M,Zarković N,Hrzenjak M,Ilić Z

    更新日期:1993-11-01 00:00:00

  • Clinical experience with hyperthermia in conjunction with radiation therapy.

    abstract::The authors have reviewed the medical records of 421 sessions of hyperthermia treatments in 73 patients treated between 1987 and 1992 at the University Heights Cancer Center and the Indiana University Medical Center in Indianapolis, Ind. Temperatures attained during the course of therapy on each patient have been aver...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227209

    authors: Shidnia H,Hornback N,Ford G,Shen RN

    更新日期:1993-09-01 00:00:00

  • Aspirin shares a short-term effect, inhibition of pyruvate kinase activity with tumor-promoting agents, but fails to promote rat liver carcinogenesis.

    abstract::Since aspirin was found to cause a persistent decrease in pyruvate kinase activity, which is a prominent characteristic of the hepatic promoters, the effect of aspirin on hepatic tumorigenesis in the rat has been studied. Male Wistar rats were initiated with a diet containing 0.06% 3'-methyl-4-dimethylamino-azobenzene...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227195

    authors: Yanagi S,Yamashita M,Hiasa Y

    更新日期:1993-07-01 00:00:00

473 条记录 8/12 页 « 12...456789101112 »